<DOC>
	<DOCNO>NCT00258154</DOCNO>
	<brief_summary>The study conduct demonstrate vaccine prevent gastroenteritis due rotavirus may administer concomitantly INFANRIX ( tm ) hexa without impair safety immunogenicity either vaccine .</brief_summary>
	<brief_title>V260 Study : Concomitant Use V260 INFANRIXâ„¢ Hexa Healthy Infants ( V260-010 )</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant per investigator , 6 12 week age History congenital abdominal disorder , intussusception , abdominal surgery Known suspect impairment immunological function Known hypersensitivity component rotavirus vaccine Prior administration rotavirus vaccine Known hypersensitivity contraindication component INFANRIX ( tm ) hexa Any infant bear know HBsAgpositive mother Prior administration oral polio vaccine Receipt one dose inactivate poliovirus vaccine , diptheria , tetanus acellular pertussis vaccine , diptheria , tetanus pertussis vaccine , Haemophilus influenzae type b vaccine , hepatitis B vaccine prior first vaccination , receipt vaccine antigen time course study Fever , rectal temperature great equal 38.1 degree C ( great equal 100.5 degree F ) time immunization History know prior rotavirus gastroenteritis , chronic diarrhea , failure thrive Clinical evidence active gastrointestinal illness Receipt intramuscular , oral , intravenous corticosteroid treatment within 2 week prior vaccination Infants reside household immunocompromised person Prior receipt blood transfusion blood product Participation another clinical study within 42 day begin anytime duration current clinical study Any infant adequately follow safety contact visit History seizure disorder prior history follow safety contact visit Any condition , opinion investigator , may interfere evaluation study objective</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>